DNA Genotek (Canada) and Microba Life Sciences (US) are Leading Players in the Microbiome Diagnostics Market
The global microbiome diagnostics market is projected to reach USD 300 million by 2028 from USD 146 billion in 2023, at a CAGR of 15.5% during the forecast period. The microbiome diagnostics market is driven by the rising incidence of diseases, the collaborative efforts between the microbiome industry and academia for microbiome research and the growing demand for personalized medicine. The top players in this market are Microba Life Sciences (US), DNA Genotek (Canada), and Genetic Analysis AS (Norway). These players hold leading positions in the market owing to their broad product offerings in the microbiome diagnostics market. These mentioned players have undertaken various organic and inorganic growth strategies such as product launches and approvals, collaborations, and agreements to retain their position in the market.
DNA Genotek (Canada) held the leading position in the microbiome diagnostics market in 2022. The company has a strong presence in the North American region and seeks to further strengthen its geographical presence by establishing its business operations in emerging markets. The company's strong product portfolio has helped it maintain its market presence.
To know about the assumptions considered for the study download the pdf brochure
Microba Life Sciences (US) accounted for the largest share of nearly 5-10% in 2022. The company’s vast product portfolio, including microbiome diagnostic products, is the primary factor for its significant share in the market
Genetic Analysis AS (Norway) held the third largest share of 3-5% of the microbiome diagnostics market in 2022. GA company focuses on research & development, production, laboratory analysis, marketing, and distribution. The company is providing a CE-marked gut microbiota analysis for testing bacterial imbalance in IBD and IBS patients. The company’s focus on product development and launches helps it to maintain its market position. In 2023, The company received a GA license from the Thailand Food and Drug Administration (Thai FDA) authority for the GA-map Dysbiosis Test in Thailand.
Related Reports:
Microbiome Diagnostics Market by Product (Kits & Reagents, Instruments), Technology (16s rRNA Sequencing, Shot Gun Metagenomics, Metatranscriptomics), Sample (Fecal, Saliva, Skin), Application (GI, Metabolic Disorders) - Global Forecast to 2028
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
